Clinical Trial Update: Immunotherapy in Patient With Poor General Condition [Phase 2]

View source ↗

Summary

A Phase 2 trial update reports on immunotherapy for patients with advanced non-small cell lung cancer and poor general condition. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Non-small Cell Lung Cancer Stage IV | Phase 2 | Status: COMPLETED